Artiva Biotherapeutics Inc
ARTV3.010USD
+0.180+6.36%
Close 08/04, 16:00（ET）Quotes delayed by 15 min
0.000USD0.000After-hours (ET)
73.33MMarket Cap
LossP/E TTM
Artiva Biotherapeutics Inc
3.010
+0.180+6.36%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q2
FY2023Q1
FY2022Q1
Operating cash flows (indirect method)
Cash flow from continuing operating activities
-31.52%-19.84M
---14.65M
---11.61M
-16.33%-13.69M
-5.92%-15.09M
---11.76M
-47.38%-14.24M
---9.66M
Net income from continuing operations
-45.46%-20.31M
---16.09M
---17.47M
-58.13%-17.84M
16.47%-13.96M
---11.28M
-37.88%-16.72M
---12.12M
Operating gains losses
6.98%628.00K
--614.00K
--627.00K
12.08%603.00K
1.56%587.00K
--538.00K
246.11%578.00K
--167.00K
Other non-cash items
-96.47%-723.00K
---1.04M
---659.00K
-1850.00%-273.00K
---368.00K
---14.00K
--0.00
----
Change in working capital
50.70%-1.49M
---311.00K
--3.01M
99.80%-7.00K
-4812.50%-3.02M
---3.46M
-93.11%64.00K
--929.00K
-Change in receivables
-351.43%-88.00K
--555.00K
--760.00K
116.91%262.00K
104.26%35.00K
---1.55M
-9.89%-822.00K
---748.00K
-Change in prepaid expenses
19.87%-750.00K
--176.00K
---1.50M
-77.39%296.00K
-291.63%-936.00K
--1.31M
72.14%-239.00K
---858.00K
-Change in other current assets
719.35%254.00K
--31.00K
--32.00K
3.33%31.00K
-6.06%31.00K
--30.00K
--33.00K
----
-Change in other current liabilities
----
----
--0.00
100.00%0.00
-100.00%0.00
---1.55M
110.67%72.00K
---675.00K
Cash from non-recurring investing activities
Cash from operating activities
-31.52%-19.84M
---14.65M
---11.61M
-16.33%-13.69M
-5.92%-15.09M
---11.76M
-47.38%-14.24M
---9.66M
Investing cash flow
Net cash from continuing investing activities
2738.89%511.00K
--64.00K
--96.00K
-20.14%464.00K
-99.03%18.00K
--581.00K
209.30%1.86M
--602.00K
Capital expenditures
2738.89%511.00K
--64.00K
--96.00K
-20.14%464.00K
-99.03%18.00K
--581.00K
209.30%1.86M
--602.00K
Net cash flow from disposal of fixed assets
2738.89%511.00K
--64.00K
--96.00K
-20.14%464.00K
-99.03%18.00K
--581.00K
209.30%1.86M
--602.00K
Net cash flow from investment products
6.96%10.48M
---902.00K
---130.53M
108.90%1.81M
--9.80M
---20.37M
--0.00
----
Cash from non-current investing activities
Net cash flow from investing activities
1.93%9.97M
---966.00K
---130.63M
106.44%1.35M
625.35%9.78M
---20.95M
-209.30%-1.86M
---602.00K
Financing cash flow
Cash flow from continuous financing activities
--239.00K
---30.00K
--163.87M
-16260.00%-1.62M
----
--10.00K
96.07%-12.00K
---305.00K
Net cash flow from debt Issuance/repayment
---33.00K
---33.00K
---38.00K
---78.00K
----
----
----
----
Net cash flow from common stock issuance/repurchase
--134.00K
--0.00
--166.51M
----
----
---12.00K
---12.00K
----
Net cash flow from preferred stock issuance/repurchase
----
----
----
----
----
----
----
--0.00
Proceeds from stock option exercised by employees
--138.00K
--23.00K
--6.00K
0.00%22.00K
----
--22.00K
----
--199.00K
Net cash flow from other financing activities
----
---20.00K
---2.60M
---1.56M
----
----
----
---504.00K
Net cash from non-recurrent financing activities
Net cash from financing activities
--239.00K
---30.00K
--163.87M
-16260.00%-1.62M
----
--10.00K
96.07%-12.00K
---305.00K
Net cash flow
Beginning cash balance
-24.68%40.49M
--56.14M
--34.51M
-44.08%48.46M
-47.69%53.76M
--86.66M
-36.23%102.78M
--161.17M
Current period cash flow changes
-81.58%-9.63M
---15.65M
--21.63M
57.34%-13.95M
67.09%-5.30M
---32.71M
-52.46%-16.12M
---10.57M
Ending cash balance
-36.31%30.86M
--40.49M
--56.14M
-36.04%34.51M
-44.08%48.46M
--53.95M
-42.46%86.66M
--150.60M
Free cash flow
-34.75%-20.35M
---14.71M
---11.71M
-14.61%-14.15M
6.22%-15.10M
---12.35M
-56.88%-16.11M
---10.27M
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
